Ehmet Health

Executive Summary

Ehmet Health is a private medical device company founded in 2021 and headquartered in San Francisco, developing advanced radiotherapy solutions to improve cancer care accessibility and precision. The company’s core products include the KODA ONE proton therapy system and a dedicated breast radiotherapy system, both designed to enhance treatment accuracy while reducing operational complexity and cost. By unifying radiation oncology platforms, Ehmet aims to expand global access to life-saving treatments, particularly in underserved regions. The company operates in the radiopharmaceuticals category and remains in early commercial stages, with no disclosed funding or valuation data.

Upcoming Catalysts (preview)

• H1 2027FDA 510(k) clearance for KODA ONE proton therapy system45% success
• H2 2026Series A funding round to support clinical trials and commercialization55% success
• Q4 2026Strategic partnership with a major cancer center for clinical validation40% success